The Nanosonics (ASX:NAN) share price is soaring 9% on Tuesday

What could be giving Nanosonics shares a boost on Tuesday?

| More on:
A group of three scientists talking excitedly while working in a lab on a diabetes test developed by Proteomics International Laboratories which is an ASX share tipped to explode by Alto Capital

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Nanosonics Ltd (ASX: NAN) share price is roaring upwards today despite no announcements from the company.

In afternoon trade, shares in the infection prevention company are up 8.63% to $6.04 apiece. Consequently, the Nanosonics share price is 26.8% away from its 52-week high of $8.25.

Could Nanosonics be a buy?

Although there is a lack of news regarding Nanosonics on Tuesday, a broker note was recently published on the healthcare company.

According to the analysts at Morgans, the Nanosonics share price could have more upside awaiting shareholders. Ostensibly, the team of analysts has placed an add rating on the Trophon manufacturer, while simultaneously cutting its price target to $6.97.

However, even with the reduced price target, this would suggest a further 15.4% upside to the Nanosonics share price. Perhaps investors are still absorbing this proposition on Tuesday, as the shares are bid higher.

Another viewpoint, the market might be paying more attention to shares primed for the nation's reopening after months of COVID-19 restrictions. Healthcare shares with exposure to elective surgery have struggled throughout the pandemic. On Wednesday last week, New South Wales Health announced the return of non-urgent elective surgery across Greater Sydney.

At the time, NSW health deputy secretary Wayne Jones stated: "Thanks to the extraordinarily high vaccination rates across the state and declining community transmission of COVID-19, patients can now have their non-urgent surgery."

Investors might be speculating over the potential for an increase in Nanosonics Trophon consumables following the return of elective surgeries.

Nanosonics share price snapshot

Nanosonics shares have been range-bound since late 2019. During this time, the company's shares have traded between $4.65 and approximately $8.00. As a result, Nanosonics' volatility is above the broader market average.

In addition, Nanosonics has returned 11.4% over the past year. Meanwhile, the S&P/ASX 200 Index (ASX: XJO) has outperformed the company, delivering a return of 21%.

In terms of valuation, the company currently trades on a price-to-earnings (P/E) ratio of 208 times based on the current Nanosonics share price.

Motley Fool contributor Mitchell Lawler has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended Nanosonics Limited. The Motley Fool Australia owns shares of and has recommended Nanosonics Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

A young woman holds an open book over her head with a round mouthed expression as if to say oops as she looks at her computer screen in a home office setting with a plant on the desk and shelves of books in the background.
Healthcare Shares

This ASX All Ords share is diving 18% as inflation pain draws blood

This healthcare company delivered a trading update at its annual general meeting today.

Read more »

Shot of a young scientist using a digital tablet while working in a lab.
Healthcare Shares

Up 427% this year, why today is a big day for Mesoblast shares

Why is everyone talking about Mesoblast shares on Friday?

Read more »

A man holds his hand under his chin as he concentrates on his laptop screen and reads about the ANZ share price
Healthcare Shares

Is this beaten-down ASX healthcare share a bargain buy now?

One expert has given their view on this stock.

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Healthcare Shares

3 ASX healthcare shares going gangbusters on Thursday

Investors are sending these ASX healthcare stocks soaring today. But why?

Read more »

Two lab workers fist pump each other.
Healthcare Shares

Is it time to cash in on Sigma shares?

Shares have extended after the Chemist Warehouse merger.

Read more »

Person holding Australian dollar notes, symbolising dividends.
Healthcare Shares

Buy this ASX 200 share that is swimming in cash

Bell Potter sees potentially big returns on offer from this cashed-up stock.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

Are CSL shares a buy after the biotech's FY25 forecasts?

Brokers continue to weigh in.

Read more »

Female pharmacist smiles with a digital tablet.
Healthcare Shares

Are Wesfarmers or Sigma shares a better buy in the pharmacy arena?

These two stocks are both leaders in the industry.

Read more »